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Abstract
Background: Caffeine is one of the most widely consumed pharmacologically active substances. Its acute effect on
myocardial blood flow is widely unknown. Our aim was to assess the acute effect of caffeine in a dose corresponding to two
cups of coffee on myocardial blood flow (MBF) in coronary artery disease (CAD).
Methodology/Principal Findings: MBF was measured with
15O-labelled H2O and Positron Emission Tomography (PET) at
rest and after supine bicycle exercise in controls (n=15, mean age 58613 years) and in CAD patients (n=15, mean age
6169 years). In the latter, regional MBF was assessed in segments subtended by stenotic and remote coronary arteries. All
measurements were repeated fifty minutes after oral caffeine ingestion (200 mg). Myocardial perfusion reserve (MPR) was
calculated as ratio of MBF during bicycle stress divided by MBF at rest. Resting MBF was not affected by caffeine in both
groups. Exercise-induced MBF response decreased significantly after caffeine in controls (2.2660.56 vs. 2.0260.56,
P,0.005), remote (2.4060.70 vs. 1.7860.46, P,0.001) and in stenotic segments (1.9060.41 vs. 1.3860.30, P,0.001).
Caffeine decreased MPR significantly by 14% in controls (P,0.05 vs. baseline). In CAD patients MPR decreased by 18%
(P,0.05 vs. baseline) in remote and by 25% in stenotic segments (P,0.01 vs. baseline).
Conclusions: We conclude that caffeine impairs exercise-induced hyperaemic MBF response in patients with CAD to a
greater degree than age-matched controls.
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Introduction
Caffeine is a xanthine derivative and one of the most widely
consumed pharmacologically active substances. As caffeine
consumption has been linked to a potential adverse cardiovascular
outcome the effects of coffee drinking on heart disease have been
extensively studied in the past decades. The existing outcome data
on the long-term effect of caffeine consumption on human health
is inconsistent and therefore subject of an ongoing controversy [1].
The inconsistency of the literature may in part be due to
differences in study design or the long time between the assessment
of coffee intake and the occurrence of cardiovascular events in
other reports [2]. Even less is known about the acute impact of
caffeine on MBF, although caffeine and related naturally
occurring xanthine derivatives are estimated to be consumed by
80% of the adult population in western countries [3]. While one
follow-up study found a beneficial effect of coffee [4], some but not
all prospective and epidemiological studies have shown an
association of coffee drinking with increased cardiovascular
morbidity and mortality [1,5–8] with some results supporting a
dose-dependent risk of a cardiovascular event [5]. A recent study
with a case crossover design suggests that transient exposure to
coffee might represent a trigger of a first nonfatal myocardial
infarction [6]. Similarly, the role of coffee in the development of
cardiovascular risk factors is controversial, as it has been linked to
both elevated [7] and reduced [8] but also to unchanged blood
pressure [9]. In one interesting study, coffee as well as caffeine
alone induced comparable increases in sympathetic nerve activity
and blood pressure in non-habitual coffee drinkers, whereas
habitual coffee drinkers exhibited lack of blood pressure increase
despite sympathetic nerve activation to coffee suggesting that
ingredients other than caffeine may be responsible for cardiovas-
cular activation [14]. Dietary intake of caffeine may also stimulate
local and/or systemic catecholamine release causing an alpha-2-
receptor-mediated coronary vasomotion [10]. In addition, caffeine
might directly alter the vasomotor tone by antagonizing A1, A2A
and A2B adenosine receptors on smooth muscle cells of the vessel
wall and herewith reduce adenosine-mediated vasodilatation
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response to exercise stress [18–20]. In fact, we recently showed
that oral intake of caffeine at a dose corresponding to two cups of
coffee significantly decreases bicycle exercise-induced hyperaemic
MBF response in healthy volunteers [11] suggesting that
hyperaemic response to exercise may at least in part depend on
intrinsic adenosine production [12,13]. Interestingly, the adverse
effect of caffeine on hyperaemic response to exercise was even
more pronounced during exposure to hypoxia [11], a situation
mimicking the oxygen deprivation found in coronary artery
disease (CAD) patients in whom compromised compensatory
mechanisms do not allow adequate MBF increase to match the
exercise-induced increase in oxygen consumption [14]. As
adenosine production is linked to myocardial pO2 [15] and the
major stimulus for its production seems to be an imbalance
between oxygen delivery and oxygen demand we studied the
hypothesis that caffeine consumption impairs the hyperaemic
MBF response to exercise in CAD patients.
Results
MBF was assessed using positron emission tomography (PET) at
rest and during bicycle exercise at baseline and after oral
administration of caffeine 200 mg. At baseline, caffeine level was
5.865.8 mmol/L in controls and increased fifty minutes after
caffeine ingestion to 27.769.3 mmol/L (P,0.001 vs. baseline). In
CAD patients caffeine level increased from 2.163.5 mmol/L to
20.669.9 mmol/L (P,0.001 vs. baseline). In both groups heart
rate, blood pressure, and rate-pressure product (RPP; systolic
blood pressure x heart rate) were not affected by caffeine neither at
rest nor at peak exercise (Table 1). Comparable values for absolute
and percent predicted workload was achieved by controls
(95630 Watts; 101620%) and CAD patients (106626 Watts;
97611%, P=ns vs. controls) in the supine position within the
scanner.
In the control group mean global resting MBF remained
unchanged after caffeine ingestion (1.21 vs. 1.26 mL/min/g,
P=ns), while bicycle exercise-induced hyperaemic MBF decreased
significantly by 11% (2.2660.56 vs. 2.0260.56 mL/min/g,
P,0.005) as reflected by a significant increase in coronary
resistance (+14%, P,0.05). This resulted in a significant decrease
in exercise MPR (214%, P,0.05) (Table 2). MBF in stenotic
segments of CAD patients (0.9460.26 mL/min/g) was lower than
in remote segments (1.160.23 mL/min/g, P,0.05) and lower
than global MBF in age-matched controls (P,0.05). Caffeine had
no significant impact on MBF at rest neither in remote (29%,
P=ns) nor in stenotic segments (23%, P=ns). Exercise-induced
hyperaemic MBF was significantly lower in stenotic
(1.9060.41 mL/min/g) compared to remote segments
(2.4060.70 mL/min/g, P,0.05) and compared to controls
(P,0.05) before caffeine (baseline) and decreased significantly
after caffeine by 26% in remote (P,0.001 vs. baseline) and by
27% in stenotic segments (P,0.001 vs. baseline). Thus, the
inhibitory effect of caffeine on MBF response to exercise was
significantly less pronounced in controls than in CAD patients
(P,0.05) (Figure 1) in whom MPR was significantly affected by
caffeine with a decrease by 18% in remote (P,0.05) and by 25%
in stenotic segments (P,0.01) (Figure 2). Accordingly, caffeine
caused a significant increase in coronary resistance during bicycle
exercise by 34% (P,0.001) in remote and by 38% in stenotic
segments (P,0.001) (Figure 3).
Discussion
Reproducibility and Generalizability of the findings
Our data provide evidence that caffeine consumption at a dose
corresponding to two cups of coffee significantly affects myocardial
blood flow in humans. This is line with the results of former
studies, suggesting that the very effect of caffeine on myocardial
blood flow is reproducible. Indeed, we showed in a recent study
that oral intake of caffeine at the same dose as in the present study
significantly decreases bicycle exercise-induced myocardial hyper-
aemic flow response in young healthy volunteers, particularly
during hypoxia [11]. The effect of caffeine in the present study was
most pronounced during physical exercise in CAD patients
resulting in a significant decrease in myocardial perfusion reserve.
The largest decrease in exercise-induced hyperaemic MBF by
caffeine was found in myocardial regions subtended by stenotic
coronary arteries of CAD patients. Accordingly, caffeine decreased
MPR in CAD patients predominantly in the same segments. This
is reflected by a marked increase in coronary resistance at exercise
in these segments without any change in systemic hemodynamic
Table 1. Hemodynamics.
Age-matched controls (n=15) CAD Patients (n=15)
Rest Baseline Caffeine P Baseline Caffeine P
SBP (mmHg) 1316160 1336180 ns 1326140 1336170 ns
DBP (mmHg) 78611 81690 ns 76613 77610 ns
MAP (mmHg) 96611 98610 ns 95612 96610 ns
HR (bpm) 68611 67613 ns 65611 64611 ns
RPP (mmHg6bpm) 887061256 880761280 ns 858961991 855161670 ns
Peak Exercise Baseline Caffeine P Baseline Caffeine P
SBP (mmHg) 1676240 1736210 ns 1666190 1736170 ns
DBP (mmHg) 97613 1006130 ns 93615 98614 ns
MAP (mmHg) 1186130 1246130 ns 1186140 1236130 ns
HR (bpm) 1186190 1166250 ns 1136170 1136190 ns
RPP (mmHg6bpm) 19515636020 20105647990 ns 18814642380 19459638260 ns
DBP=diastolic blood pressure (BP); HR=heart rate; MAP=mean BP; RPP=rate pressure product; SBP=systolic BP.
P-values are given for the comparison of baseline vs. caffeine.
doi:10.1371/journal.pone.0005665.t001
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former studies, the microcirculatory changes due to the direct
effect of caffeine can be considered as real as well as reproducible.
Mechanisms supporting the findings and clinical
implications
The present study supports that exercise-induced hyperaemic
MBF response may at least in part be mediated by intrinsic
adenosine and provides evidence that CAD patients are more
susceptible to the antagonizing effects of caffeine than controls as
their hyperaemic MBF response to exercise was significantly more
impaired. Accordingly, previous reports in experimental animals,
where an increase in MBF after aminophylline infusion has been
attributed to a stimulation of alpha-1-adrenoreceptors when
adenosine release is not prominent while during situations with
increased adenosine release the inhibitory effect of aminophylline
on adenosine receptors predominated over the beneficial effects of
alpha-1-adrenoreceptor stimulation [23]. The finding of signifi-
cantly decreased MPR after caffeine consumption seems not to
have a direct and clinically evident negative impact in daily life in
healthy individuals, indicating that a MPR of about 1.67 is largely
sufficient. In stenotic segments of CAD patients, however, the
MPR decrease was significantly more pronounced than in remote
segments. This may raise questions about the safety of caffeine in
patients with yet impaired MPR. Importantly, measured serum
caffeine levels after ingestion of 200 mg of caffeine are comparable
with serum caffeine levels observed after drinking two cups of
coffee or a triple espresso [24], suggesting that serum concentra-
tions measured and reported in our study are likely to occur with
common ingestion of caffeine containing beverages. Several
mechanisms may be involved in the differential effects of caffeine
on exercise MBF in CAD versus controls. First, adenosine acts as
an endogenous determinant of ischemic tolerance [25] and
adenosinergic cardioprotection plays a key role in ischemic
Table 2. Myocardial Blood Flow, Coronary Resistance and Flow Reserve.
Age-matched
controls
(n=15)
CAD patients
(n=15)
remote
segments
stenotic
segments
Baseline Caffeine P Baseline Caffeine P Baseline Caffeine P
MBF rest 1.2160.32 1.2660.32 ns 1.160.23 1.060.26 ns 0.9460.26*
{ 0.9160.24
{ ns
MBF ex 2.2660.56 2.0260.56 ,0.005 2.460.7 1.7860.46 ,0.001 1.960.41* 1.3860.3*
{ ,0.001
Cor Res rest 85627 82620 ns 89617 102632 ns 108631*
{ 116652
{ ns
Cor Rest ex 44613 50617 ,0.05 44617 59620 ,0.001 53617* 73620*
{ ,0.001
MPR 1.9460.61 1.6760.59 ,0.05 2.2460.73 1.8460.54 ,0.05 2.160.53 1.5860.38 ,0.01
MBF, myocardial blood flow (ml/min/g). Cor Res, coronary resistance (mmHg/ml/min/g). MPR, myocardial perfusion reserve (relative values). Ex, exercise.
*P,0.05 for the comparison with remote segments.
{P,0.05 for the comparison with age-matched controls.
doi:10.1371/journal.pone.0005665.t002
Figure 1. Exercise-induced hyperemia: effects of caffeine. Caffeine decreases exercise-induced hyperaemic MBF. This effect was most
prominent in stenotic segments of CAD patients. *P,0.005 for the comparison versus baseline.
doi:10.1371/journal.pone.0005665.g001
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susceptible to antagonizing effects of caffeine. Second, the
concentration-response relationship for interstitial adenosine-
induced coronary vasodilatation is reported to be steep with a
large receptor reserve for adenosine to cause an increase in MBF
[26]. Receptor reserve is a pharmacological term for the
phenomenon wherein the increment of functional response caused
by an increase of agonist concentration is proportionately greater
than the increment of receptor occupancy [26]. Studies with both
agonists and antagonists indicate substantial yet submaximal
receptor activation by endogenous adenosine during ischemia
[27] supporting the possibility of reduced receptor reserve in
ischemic myocardium. This may also contribute to the enhanced
caffeine effect in ischemic segments. We have used bicycle exercise
stress for stimulation of hyperaemic MBF as a physiological
stimulus reflecting the natural response of the coronary arteries
while a pharmacologic stimulus alone may have been of limited
value in the assessment of the pathophysiological changes
[20,24,26].
Limitations and strengths of the study
A limitation of the present study is that data acquisition was
obtained in the immediate post-exercise period when the cardiac
power output is considerably decreased and when flow is also
expected to fall rapidly. Therefore, we assess the impact of caffeine
on an MBF value representing the average value over 5 minutes of
recovery, rather than the peak MBF value at maximal exercise.
Similarly, MPR during exercise might have been slightly higher
than the value assessed post exercise. In addition, no placebo-
controlled study design was followed. However, the fact that every
subject was used as its own control strengthens our results and the
validity of this method has been recently documented in a
repeatability study [17]. For safety reasons the study did not allow
inclusion of CAD patients with high-grade stenoses. As a result,
Figure 3. Coronary resistance during physical exercise. Coronary resistance at exercise increased in all groups. A massive increase in resistance
was found in stenotic segments. {P,0.05 for the comparison versus remote. *P,0.05 for the comparison versus remote segments and age-matched
controls.
doi:10.1371/journal.pone.0005665.g003
Figure 2. Myocardial perfusion reserve: effects of caffeine. Caffeine decreases myocardial perfusion reserve. This effect was most pronounced
in stenotic segments of CAD patients. *P,0.05 for the comparison versus baseline.
doi:10.1371/journal.pone.0005665.g002
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depression. In summary, our results show that exercise-induced
hyperaemic MBF response can be blunted by caffeine. This may
jeopardize patients with CAD.
Conclusion
We conclude that caffeine impairs exercise-induced hyperaemic
MBF response in patients with CAD to a greater degree than age-
matched controls.
Materials and Methods
Study population
We studied 15 CAD patients (mean age 6169 years, 13 males, 2
females) with angiographically documented single- or two-vessel
disease, with a luminal stenosis of more than 50% in at least one
epicardial artery. All patients had stable CAD in the Canadian
Cardiovascular Society (CCS) functional class II to III. Only
patients with mild (.50% to 70%) or moderate (.70% to 90%)
lesions were included in order to allow meaningful exercise levels
without safety concerns. The age-matched control group consisted
of 15 healthy volunteers (mean age 58613 years, 5 males, 10
females, P=ns vs. patients). Exclusion criteria were arrhythmia of
any kind, a pathological ECG, existing cardiovascular risk factors,
current medication affecting myocardial blood flow and/or
cardiovascular risk factors and a more than low clinical probability
for CAD [16]. All participants were habitual coffee drinkers but
refrained from ingesting caffeinated beverages or food for
24 hours before the study.
Study protocol
With the subject’s feet attached to a bicycle ergometer (model
380 B, Siemens-Elema AG, Switzerland) MBF was measured at
rest and during supine bicycle exercise-induced hyperemia in all
study participants as recently documented [14,17]. Exercise was
started at 25–50 Watts (W), and workload was increased every
minute to reach 100% of the predicted value for upright bicycle
exercise after 5 minutes. Thereafter, 200 mg of oral caffeine
(GlaxoSmithKline, Pittsburgh, PA, USA) - a dose corresponding
to two cups of coffee [3] – was administered to each subject and
fifty minutes later (at the time of expected serum caffeine peak
level) all MBF measurements were repeated. Blood pressure was
continuously monitored by a Finapress Monitor (BOC; Inc.,
Englewood, CO, USA) and recorded every minute at rest, at each
exercise level and during recovery. The ECG was monitored
continuously and a 12-lead ECG was recorded each minute.
Serum caffeine concentration was determined before and
50 minutes after caffeine ingestion.
Ethics Statement
The local ethics committee approved this study protocol. All
subjects gave informed and written consent.
Image Acquisition
Images were acquired on a Discovery LS PET/CT scanner (GE
Healthcare), an integration of an Advance NXi PET scanner with
a LightSpeed Plus 4-row helical CT scanner at the PET Centre of
the University Hospital Zurich. During the 50-minute break a CT-
based attenuation correction was performed [18]. Starting after
the background frame, a dose of 500–700 MBq of
15O-water was
injected as an intravenous bolus over 20 s at an infusion rate of
24 mL/min to assess MBF at rest and after bicycle exercise at
baseline conditions and after ingestion of caffeine.
Image Processing and myocardial perfusion
Images were analyzed with a pixel-wise modelling software
developed at our institution (PMOD Technologies Ltd.; Zurich,
Switzerland) [20,24,26]. Myocardial images were then generated
directly from the dynamic
15O-water study by factor analysis [19].
After reorienting the factor images along the heart axis to form
vertical long-axis, horizontal long-axis, and short-axis-slices,
regions of interest were drawn within the left ventricular cavity
and myocardium on consecutive image planes and projected onto
the dynamic
15O-water images to generate blood time-activity-
curves. These curves were fitted to a single tissue compartment
tracer kinetic model to give values of MBF (mL/min/g)
[14,19,20,21]. For the analysis of the controls the segments were
grouped to obtain a mean global value for the whole left ventricle.
In patients all segments were assigned to either stenosis-dependent
(i.e. subtended by a stenotic coronary artery) or remote according
to the coronary angiography while blinded for the MBF values by
two independent and blinded readers as previously described
[14,22]. Coronary resistance (mmHg/mL/min/g) was calculated
as the ratio of mean arterial pressure to MBF at rest and after
bicycle stress as reported [17,19,20,21]. Myocardial perfusion
reserve (MPR) was defined as the ratio of exercise-induced
hyperaemic MBF to resting MBF.
Statistical analysis
Data are reported as mean values6standard deviation (SD) if
not otherwise stated. Demographic data were compared using the
chi-square test. Comparisons of hemodynamic and MBF values
were performed by ANOVA statistics for repeated measures.
When the P-value was ,0.05, Sheffe’s procedure was applied. For
paired comparison of stenotic versus remote segments and
unpaired comparison of patients versus age-matched controls, a
paired and an unpaired t-test were used, respectively. The number
of patients necessary (in each group) was calculated to be fewer
than 15, for detecting a minimum clinically relevant difference in
hyperaemic MBF of 20% between baseline and caffeine with an
alpha of 0.05 and a power (1-beta) of 0.8.
The authors had full access to the data and take responsibility
for its integrity. All authors have read and agree to the manuscript
as written.
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